Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome. The discussion centered on diverse treatment strategies for myelodysplastic ...
Please provide your email address to receive an email when new articles are posted on . Most patients with newly diagnosed high-risk myelodysplastic syndrome do not receive guideline-recommended ...
Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...
Geron is planning to submit a New Drug Application (NDA) for imetelstat, a treatment for low to intermediate-1 risk myelodysplastic syndromes (MDS), in 2023 after favorable Phase 3 trial results.
Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...
According to Ira Zackon, MD, a hematologist-oncologist and senior medical director at Ontada, a retrospective study of over ...
Financial considerations in MDS treatment are discussed. In this segment of the discussion on managing myelodysplastic syndrome (MDS), the focus shifted to the economic implications of MDS management, ...
Myelodysplastic syndromes (MDS) are a group of disorders that affect bone marrow – the spongy tissue inside your bones where new blood cells are made. Bone marrow contains stem cells, or parent cells ...
13don MSN
Chromatin accessibility maps reveal how stem cells drive myelodysplastic syndrome progression
Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback